NUCLEUS
Nucleus Software Exports
Each stock's 10,000-path forecast, rendered as light.
Nucleus Software Exports (NUCLEUS) Stock Analysis & Case Study
Is NUCLEUS a good buy? The data-driven verdict.
Nucleus Software Exports (NUCLEUS) trades at ₹783,on the numbers it worth a closer look, a Downstox Snapshot Score of 55/100.
On the numbers, Nucleus Software Exports (NUCLEUS) worth a closer look, a Downstox Snapshot Score of 55/100, weighing fairly valued at 15.4× earnings, ROE of 15.5%, a 17% model probability of trading higher in a year. Below: the full bull case, bear case, sector-relative valuation, and a probability-weighted price target for 2027–2031.
Last updated . Data snapshot for research, not investment advice.
NUCLEUS fundamentals at a glance, PE, PB, ROE, ROCE, market cap, dividend yield
Is NUCLEUS overvalued? NUCLEUS P/E vs its sector
NUCLEUS's P/E of 15.4× sits above the sector peer median of 15.4×, so on earnings it screens in line with peers, while its 1.60% dividend yield is below the peer median of 1.65%.
NUCLEUS share price target 2027, 2028, 2029, 2030, 2031, a probability view
Unlike a single guessed number, this is a probability-weighted range from a 10,000-path Monte-Carlo simulation on 2.0y of NUCLEUS history (-31%/yr drift, 43%/yr volatility).
| Year | Low (P10) | Median target (P50) | High (P90) | Upside vs today |
|---|---|---|---|---|
| NUCLEUS 2027 | ₹304 | ₹527 | ₹909 | -33% |
| NUCLEUS 2028 | ₹162 | ₹353 | ₹761 | -55% |
| NUCLEUS 2029 | ₹91 | ₹237 | ₹607 | -70% |
| NUCLEUS 2030 | ₹53 | ₹158 | ₹458 | -80% |
| NUCLEUS 2031 | ₹32 | ₹105 | ₹349 | -87% |
Median (P50) is the central estimate; the P10–P90 band is the 80% confidence range. Probabilities, not promises.
What is the probability NUCLEUS goes up, or doubles?
The bull case for NUCLEUS
- A 15.4× P/E sits in the fair-value band, neither cheap nor stretched.
- A healthy 15.5% return on equity.
- Strong ROCE (20.0%) shows the core business earns well above its cost of capital.
- Upside scenario: the model's optimistic (P90) 3-year path reaches ₹607.
The bear case & risks
- The probability model is cautious 12 months out, only a 17% chance of finishing above today's price.
- Downside scenario: the model's pessimistic (P10) 3-year path falls to ₹91.
NUCLEUS volatility & expected range, how bumpy is the ride?
Over the last 2.0 years NUCLEUS compounded at -31%/year with annualized volatility of 43%. That volatility implies a 1-year 80% range of ₹304–₹909, the honest backbone behind any single price target.
NUCLEUS price forecast, the full 60-month probability fan
NUCLEUS price probability fan
Each band shows where 10,000 simulated paths land. The wider the fan, the more uncertainty.
Probability of key outcomes
What are the odds NUCLEUS hits common targets within the simulated horizon?
Full multi-horizon detail on the NUCLEUS price target & forecast page.
NUCLEUS Piotroski F-Score: 4/9, how financially strong is it?
The Piotroski F-Score grades financial strength on nine profitability, leverage and efficiency checks. NUCLEUS scores 4/9,mixed financial health.
NUCLEUS MTF margin & leverage, Upstox, Zerodha, Groww, Dhan
Margin Trading Facility lets you buy NUCLEUS with part of the capital. Lower margin % = higher leverage. Rates compared across brokers (no competitor publishes this):
| Broker | Margin required | Approx. leverage |
|---|---|---|
| Upstox | 35.0% | 2.9× |
| ZerodhaCHEAPEST | 35.0% | 2.9× |
| Dhan | 40.0% | 2.5× |
Compare every broker on the NUCLEUS MTF page.
NUCLEUS vs peers,sector comparison
About Nucleus Software Exports: sector, index & market-cap context
Nucleus Software Exports (NUCLEUS) is a small-cap NSE-listed company, and a constituent of the Nifty 500 index group, with a market capitalisation of ₹2,061 Cr. See more Nifty 500 stocks.
How the NUCLEUS Snapshot Score & forecast are built
The Downstox Snapshot Score is a transparent, rules-based read of Nucleus Software Exports's public fundamentals plus a statistical forecast, not an analyst opinion. It rewards low-to-fair valuation, high ROE/ROCE, a strong Piotroski F-Score, a dividend, low volatility and a favourable probability of upside; it penalises rich valuations, weak capital efficiency, a low F-Score and high volatility. The price target is a 10,000-path Monte-Carlo simulation on real historical volatility, a distribution, not a single guess. The bull and bear cases are generated from the same data, so you always see both sides.
This is information, not investment advice. Do your own due diligence and consult a SEBI-registered adviser before investing.
NUCLEUS analysis, FAQs
Is Nucleus Software Exports (NUCLEUS) a good buy?
On the numbers, Nucleus Software Exports (NUCLEUS) worth a closer look, a Downstox Snapshot Score of 55/100, weighing fairly valued at 15.4× earnings, ROE of 15.5%, a 17% model probability of trading higher in a year. This is a data snapshot for research, not investment advice.
Is NUCLEUS overvalued or undervalued?
NUCLEUS trades at 15.4× earnings versus a peer median of 15.4×, so it screens richer than its sector peers.
What is the NUCLEUS share price target for 2031?
NUCLEUS's probability-weighted 2031 median target is ₹105, with an 80% range of ₹32–₹349 (10,000-path Monte-Carlo).
What is the probability NUCLEUS doubles in 5 years?
The modelled probability of NUCLEUS reaching ₹1,571 (2×) within 5 years is 0%.
What is the bull case for NUCLEUS?
A 15.4× P/E sits in the fair-value band, neither cheap nor stretched. A healthy 15.5% return on equity. Strong ROCE (20.0%) shows the core business earns well above its cost of capital.
What are the risks in NUCLEUS?
The probability model is cautious 12 months out, only a 17% chance of finishing above today's price.